Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Kahn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|May 27, 2026
Cutting to the ChaseJosephine Kahn, Anand Vaidya, David Roach, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery PlatformWei Jiang, Subrata Shaw, Jason Rush, et al.
Iscience|March 24, 2025
Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platformSubrata Shaw, Wei Jiang, Jason Rush, et al.
Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Nature Communications|June 30, 2022
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational statePeter G Miller, Murugappan Sathappa, Jamie A Moroco, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|May 27, 2026
Cutting to the ChaseJosephine Kahn, Anand Vaidya, David Roach, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery PlatformWei Jiang, Subrata Shaw, Jason Rush, et al.
Iscience|March 24, 2025
Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platformSubrata Shaw, Wei Jiang, Jason Rush, et al.
Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Nature Communications|June 30, 2022
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational statePeter G Miller, Murugappan Sathappa, Jamie A Moroco, et al.
Pageof 1